Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Assisted reproductive outcomes in women with different polycystic ovary syndrome phenotypes: the predictive value of anti-Müllerian hormone.

Reproductive biomedicine online - 1 May 2016

Ramezanali Fariba, Ashrafi Mahnaz, Hemat Mandana, Arabipoor Arezoo, Jalali Samaneh, Moini Ashraf

Abstract excerpt

This cross-sectional study aimed to evaluate IVF/intracytoplasmic sperm injection (ICSI) outcomes in different polycystic ovary syndrome (PCOS) phenotypes (A, B, C and D) compared with a control group and the predictive values of serum anti-Müllerian hormone (AMH) in PCOS phenotypes for main outcomes. This study evaluated 386 PCOS women and 350 patients with male factor infertility. Women with phenotypes A and C...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Mullerian Hormone
Share to Cross-Sectional Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to AMH gene

Share to Phenotype

Share to Polycystic Ovary Syndrome

Share to Pregnancy

Share to Pregnancy Outcome

Source

Identifiers

PMID: 26968928
DOI: 10.1016/j.rbmo.2016.01.010

Genes

AMH

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Assisted reproductive outcomes in women with different polycystic ovary syndrome phenotypes: the predictive value of anti-Müllerian hormone.PMID 26968928Read ↗

Elevated Anti-Müllerian Hormone as a Prognostic Factor for Poor Outcomes of In Vitro Fertilization in Women with Polycystic Ovary SyndromeSemantic proximity Read ↗

The Role of Anti-Müllerian Hormone in the Characterization of the Different Polycystic Ovary Syndrome Phenotypes.Semantic proximity Read ↗

Association of antimüllerian hormone with polycystic ovarian syndrome phenotypes and pregnancy outcomes of in vitro fertilization cycles with fresh embryo transfer.Semantic proximity Read ↗

Association between hyperandrogenism and adverse pregnancy outcomes in patients with different polycystic ovary syndrome phenotypes undergoing in vitro fertilization/intracytoplasmic sperm injection: a systematic review and meta-analysis.Semantic proximity Read ↗

Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndromeSemantic proximity Read ↗

Serum anti-Mullerian hormone levels in the main phenotypes of polycystic ovary syndrome.Semantic proximity Read ↗

The Diagnostic Performance of Antimullerian Hormone for Polycystic Ovarian Syndrome and Polycystic Ovarian MorphologySemantic proximity Read ↗

Comparison of clinical and hormonal characteristics among four phenotypes of polycystic ovary syndrome based on the Rotterdam criteria.Semantic proximity Read ↗

The Relationship of Anti-Mullerian Hormone in Polycystic Ovary Syndrome Patients With Different SubgroupsSemantic proximity Read ↗

Association of Polycystic Ovary Syndrome Phenotypes With Adverse Pregnancy Outcomes After In-Vitro Fertilization/Intracytoplasmic Sperm Injection.Semantic proximity Read ↗

Demographic, clinical characteristics, polycystic ovarian syndrome phenotypes and predictors of anti-mullerian hormone among women with PCOS at a Fertility Center in Ghana: A 5-year retrospective studySemantic proximity Read ↗

The diagnostic performance of antimullerian hormone for polycystic ovarian syndrome and polycystic ovarian morphology.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.